封面
市场调查报告书
商品编码
1762279

动物神经退化性疾病诊断市场:市场规模、占有率、趋势、产业分析报告:依产品、检测方法、动物类型、适应症、最终用途、地区划分,预测至2025-2034年

Veterinary Neurodegenerative Disease Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product, By Test, By Animal Type, By Indication, By End Use, and By Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究,预计到2034年,动物神经退化性疾病诊断市场规模将达到8.0579亿美元。本研究报告深入分析了当前的市场动态,并分析了未来的市场成长。

动物神经退化性疾病诊断是动物保健产业中的专业领域,致力于动物神经退化性疾病的检测和管理。犬认知功能障碍综合症(CDS)、猫痴呆症和马运动神经元疾病等神经退化性疾病日益被认为是老年宠物和牲畜的严重健康问题。早期准确的诊断对于管理这些疾病、改善动物福利和提高生活品质非常重要。

该市场涵盖各种诊断工具,例如先进的影像技术、脑脊髓液(CSF)分析、基因治疗和生物标记评估。人们对动物神经系统疾病的认识不断提高,加上兽医诊断技术的进步,是市场扩张的驱动力。此外, "宠物人性化" 趋势日益盛行,宠物被视为家庭成员,这导致先进兽医学支出增加,进一步刺激了神经退化性疾病诊断的需求。

动物神经退化性疾病诊断市场报告重点

依产品划分,耗材、试剂和试剂盒细分市场在动物神经系统疾病的早期检测和准确诊断中发挥着非常重要的作用,在2024年占据了主要占有率。

依检测方式划分,成像细分市场在识别动物大脑和脊髓异常方面发挥关键作用,在2024年占据了主导地位。

依动物类型划分,由于老年宠物(尤其是犬猫)神经系统疾病的盛行率不断上升,伴侣动物细分市场在2024年占据了最大占有率。

由于宠物(尤其是犬猫)神经退化性疾病的盛行率不断上升,北美动物神经退化性疾病诊断市场在2024年占据了最大占有率。

由于老年宠物数量的增加以及人们对神经系统疾病认识的不断提高,预计未来几年欧洲市场将保持强劲成长。

由于宠物饲养量的增加、可支配收入的增加以及兽医医疗保健基础设施的改善,预计亚太市场将在2034年占据重要占有率。

全球主要市场参与者包括 ACUVET BIOTECH、Antech Diagnostics, Inc.、Avacta Animal Health Limited、Heska Corporation、IDEXX Laboratories, Inc.、Life Diagnostics 和 Merck & Co.

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球动物神经退化性疾病诊断市场洞察

  • 适应症概览
  • 动物神经退化性疾病诊断市场动态
    • 驱动因素和机会
      • 全球可支配所得不断增加
      • 兽医技术进步神经学
    • 限制与挑战
      • 缺乏普遍接受的诊断测试
  • PESTEL 分析
  • 动物神经退化性疾病诊断市场趋势
  • 价值链分析

第5章 全球动物神经退化性疾病诊断市场(依产品)

  • 主要调查结果
  • 简介
  • 耗材、试剂和试剂盒
  • 设备与仪器

第6章 全球动物神经退化性疾病诊断市场(依测试)

  • 主要调查结果
  • 简介
  • 诊断影像
  • 生物标记诊断测试
  • 其他

第7章 全球动物神经退化性疾病诊断市场(依动物类型)

  • 主要调查结果
  • 简介
  • 牲畜
  • 古法师

第8章 全球动物神经退化性疾病诊断市场(依适应症)

  • 主要调查结果
  • 简介
  • 认知障碍
  • 小脑萎缩症
  • 海绵状脑病
  • 其他

第9章 全球动物神经退化性疾病诊断市场(依最终用途)

  • 主要调查结果
  • 简介
  • 兽医院和诊所
  • 兽诊断实验室
  • 其他

第10章 全球动物神经退化性疾病诊断市场(依地区)

  • 主要调查结果
  • 介绍
    • 2020-2034年动物神经退化性疾病诊断市场评估(依地区)
  • 北美
    • 2020-2034年北美:依产品
    • 2020-2034年北美:依检测
    • 2020-2034年北美:依动物类型
    • 2020-2034年北美:依适应症
    • 2020-2034年北美:依最终用途
    • 美国
    • 加拿大
  • 欧洲
    • 2020-2034年欧洲:依产品
    • 2020-2034年欧洲:依检测
    • 2020-2034年欧洲:依动物类型
    • 2020-2034年欧洲:依适应症
    • 2020-2034年欧洲:依最终用途
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 2020-2034年亚太地区:依产品
    • 2020-2034年亚太地区:依检测
    • 2020-2034年亚太地区:依动物类型
    • 2020-2034年亚太地区:依适应症
    • 2020-2034年亚太地区:依最终用途
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 2020-2034年中东和非洲:依产品
    • 2020-2034年中东和非洲:依检测
    • 2020-2034年中东和非洲:依动物类型
    • 2020-2034年中东和非洲:依适应症
    • 2020-2034年中东和非洲:依最终用途
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 中东其他地区及非洲
  • 拉丁美洲
    • 2020-2034年拉丁美洲:依产品
    • 2020-2034年拉丁美洲:依检测
    • 2020-2034年拉丁美洲:依动物类型
    • 2020-2034年拉丁美洲:依适应症
    • 2020-2034年拉丁美洲:依最终用途
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区

第11章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 合作伙伴/合作/协议/公开

第12章 公司简介

  • ACUVET BIOTECH
  • Antech Diagnostics, Inc.
  • Avacta Animal Health Limited
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Life Diagnostics
Product Code: PM5768

The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report "Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.

The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights

In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.

Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.

In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.

The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.

The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.

The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.

A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.

Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Consumables, Reagents & Kits

Equipment & Instruments

By Test Outlook (Revenue, USD Million, 2020-2034)

Imaging

MRI (Magnetic Resonance Imaging)

CT (Computed Tomography)

Others

Biomarker Diagnostic Tests

CSF (Cerebrospinal Fluid) biomarkers

Blood-based biomarkers

Others

Others

By Animal Type Outlook (Revenue, USD Million, 2020-2034)

Livestock

Sheep

Cattle

Others

Companion

Canine

Feline

Equine

Others

By Indication Outlook (Revenue, USD Million, 2020-2034)

Cognitive Dysfunction

Cerebellar Abiotrophy

Spongiform Encephalopathies

Others

By End Use Outlook (Revenue, USD Million, 2020-2034

Veterinary Hospitals and Clinics

Veterinary Diagnostic Laboratories

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Neurodegenerative Disease Diagnostics Market Insights

  • 4.1. Veterinary Neurodegenerative Disease Diagnostics Market - Indication Snapshot
  • 4.2. Veterinary Neurodegenerative Disease Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Disposable Income Worldwide
      • 4.2.1.2. Technological Advancements in Veterinary Neurology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of a universally accepted diagnostic test
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Neurodegenerative Disease Diagnostics Market Trends
  • 4.6. Value Chain Analysis

5. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • 5.3. Consumables, Reagents & Kits
    • 5.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Consumables, Reagents & Kits, by Region, 2020-2034 (USD Million)
  • 5.4. Equipment & Instruments
    • 5.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Equipment & Instruments, by Region, 2020-2034 (USD Million)

6. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 6.3. Imaging
    • 6.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Imaging, by Region, 2020-2034 (USD Million)
    • 6.3.2. MRI (Magnetic Resonance Imaging)
      • 6.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by MRI (Magnetic Resonance Imaging), by Region, 2020-2034 (USD Million)
    • 6.3.3. CT (Computed Tomography)
      • 6.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CT (Computed Tomography), by Region, 2020-2034 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
  • 6.4. Biomarker Diagnostic Test
    • 6.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Biomarker Diagnostic Test, by Region, 2020-2034 (USD Million)
    • 6.4.2. CSF (Cerebrospinal Fluid) biomarkers
      • 6.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CSF (Cerebrospinal Fluid) biomarkers, by Region, 2020-2034 (USD Million)
    • 6.4.3. Blood-based biomarkers
      • 6.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Blood-based biomarkers, by Region, 2020-2034 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • 7.3. Livestock
    • 7.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Livestock, by Region, 2020-2034 (USD Million)
    • 7.3.2. Sheep
      • 7.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Sheep, by Region, 2020-2034 (USD Million)
    • 7.3.3. Cattle
      • 7.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Cattle, by Region, 2020-2034 (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)
  • 7.4. Companion
    • 7.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Companion, by Region, 2020-2034 (USD Million)
    • 7.4.2. Canine
      • 7.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Canine, by Region, 2020-2034 (USD Million)
    • 7.4.3. Feline
      • 7.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Feline, by Region, 2020-2034 (USD Million)
    • 7.4.4. Equine
      • 7.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Equine, by Region, 2020-2034 (USD Million)
    • 7.4.5. Others
      • 7.4.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)

8. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • 8.3. Cognitive Dysfunction
    • 8.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cognitive Dysfunction, by Region, 2020-2034 (USD Million)
  • 8.4. Cerebellar Abiotrophy
    • 8.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cerebellar Abiotrophy, by Region, 2020-2034 (USD Million)
  • 8.5. Spongiform Encephalopathies
    • 8.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Spongiform Encephalopathies, by Region, 2020-2034 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 9.3. Veterinary Hospitals and Clinics
    • 9.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Hospitals and Clinics, by Region, 2020-2034 (USD Million)
  • 9.4. Veterinary Diagnostic Laboratories
    • 9.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 9.5. Others
    • 9.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

10. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Veterinary Neurodegenerative Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
  • 10.3. Veterinary Neurodegenerative Disease Diagnostics Market - North America
    • 10.3.1. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.3.2. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.3.3. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.3.4. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.3.5. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.3.7. Veterinary Neurodegenerative Disease Diagnostics Market - U.S.
      • 10.3.7.1. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.3.7.2. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.3.7.3. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.3.7.4. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.3.7.5. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.3.8. Veterinary Neurodegenerative Disease Diagnostics Market - Canada
      • 10.3.8.1. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.3.8.2. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.3.8.3. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.3.8.4. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.3.8.5. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.4. Veterinary Neurodegenerative Disease Diagnostics Market - Europe
    • 10.4.1. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.4.2. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.4.3. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.4.4. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.4.5. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.6. Veterinary Neurodegenerative Disease Diagnostics Market - UK
      • 10.4.6.1. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.6.2. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.6.3. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.6.4. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.6.5. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.7. Veterinary Neurodegenerative Disease Diagnostics Market - France
      • 10.4.7.1. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.7.2. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.7.3. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.7.4. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.7.5. France: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.8. Veterinary Neurodegenerative Disease Diagnostics Market - Germany
      • 10.4.8.1. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.9. Veterinary Neurodegenerative Disease Diagnostics Market - Italy
      • 10.4.9.1. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.10. Veterinary Neurodegenerative Disease Diagnostics Market - Spain
      • 10.4.10.1. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.11. Veterinary Neurodegenerative Disease Diagnostics Market - Netherlands
      • 10.4.11.1. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.12. Veterinary Neurodegenerative Disease Diagnostics Market - Russia
      • 10.4.12.1. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.4.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.5. Veterinary Neurodegenerative Disease Diagnostics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.6. Veterinary Neurodegenerative Disease Diagnostics Market - China
      • 10.5.6.1. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.6.2. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.6.3. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.6.4. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.6.5. China: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.7. Veterinary Neurodegenerative Disease Diagnostics Market - India
      • 10.5.7.1. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.7.2. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.7.3. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.7.4. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.7.5. India: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.8. Veterinary Neurodegenerative Disease Diagnostics Market - Malaysia
      • 10.5.8.1. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.9. Veterinary Neurodegenerative Disease Diagnostics Market - Japan
      • 10.5.9.1. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.10. Veterinary Neurodegenerative Disease Diagnostics Market - Indonesia
      • 10.5.10.1. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.11. Veterinary Neurodegenerative Disease Diagnostics Market - South Korea
      • 10.5.11.1. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.12. Veterinary Neurodegenerative Disease Diagnostics Market - Australia
      • 10.5.12.1. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.5.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.6. Veterinary Neurodegenerative Disease Diagnostics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.6.6. Veterinary Neurodegenerative Disease Diagnostics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.6.7. Veterinary Neurodegenerative Disease Diagnostics Market - UAE
      • 10.6.7.1. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.6.8. Veterinary Neurodegenerative Disease Diagnostics Market - Israel
      • 10.6.8.1. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.6.9. Veterinary Neurodegenerative Disease Diagnostics Market - South Africa
      • 10.6.9.1. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.6.10. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 10.7. Veterinary Neurodegenerative Disease Diagnostics Market - Latin America
    • 10.7.1. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
    • 10.7.2. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 10.7.3. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
    • 10.7.4. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
    • 10.7.5. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.7.6. Veterinary Neurodegenerative Disease Diagnostics Market - Mexico
      • 10.7.6.1. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.7.7. Veterinary Neurodegenerative Disease Diagnostics Market - Brazil
      • 10.7.7.1. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.7.8. Veterinary Neurodegenerative Disease Diagnostics Market - Argentina
      • 10.7.8.1. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 10.7.9. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. ACUVET BIOTECH
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Antech Diagnostics, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Avacta Animal Health Limited
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Heska Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. IDEXX Laboratories, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Life Diagnostics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Pro

List of Tables:

  • Table 1 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 2 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 3 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 4 Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 5 Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 6 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 7 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 8 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 9 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 10 North America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 11 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 12 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 13 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 14 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 15 U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 16 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 17 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 18 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 19 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 20 Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 22 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 23 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 24 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 25 Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 26 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 27 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 28 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 29 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 30 UK: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 31 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 32 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 33 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 34 France: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 35 France: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 36 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 37 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 38 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 39 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 40 Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 42 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 43 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 44 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 45 Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 46 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 47 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 48 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 49 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 50 Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 52 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 53 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 54 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 55 Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 56 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 57 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 58 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 59 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 60 Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 71 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 72 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 73 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 74 China: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 75 China: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 76 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 77 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 78 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 79 India: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 80 India: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 81 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 82 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 83 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 84 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 85 Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 86 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 87 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 88 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 89 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 90 Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 92 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 93 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 94 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 95 Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 96 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 97 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 98 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 99 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 100 South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 101 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 102 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 103 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 104 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 105 Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 121 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 122 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 123 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 124 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 125 UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 126 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 127 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 128 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 129 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 130 Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 131 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 132 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 133 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 134 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 135 South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 141 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 142 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 143 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 144 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 145 Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 146 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 147 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 148 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 149 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 150 Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 151 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 152 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 153 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 154 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 155 Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 156 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 157 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 158 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 159 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 160 Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Veterinary Neurodegenerative Disease Diagnostics Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2024 & 2034 (USD Million)
  • Figure 8. Market by Test
  • Figure 9. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2024 & 2034 (USD Million)
  • Figure 10. Market by Animal Type
  • Figure 11. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2024 & 2034 (USD Million)
  • Figure 12. Market by Indication
  • Figure 13. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2024 & 2034 (USD Million)
  • Figure 14. Market by End Use
  • Figure 15. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2024 & 2034 (USD Million)